npj Vaccines: open for submissions

If you are unable to see the message below, click here to view.

EDITOR-IN-CHIEF   Professor Alan D. Barrett (Ph.D., Director, Sealy Center for Vaccine Development, University of Texas Medical Branch at Galveston, Texas, USA) npj Vaccines is an online-only, open access, multidisciplinary journal dedicated to publishing cutting-edge research and development on human and veterinary vaccines. Led by Professor Alan D. Barrett the journal is part of the Nature Partner Journals series, and published in partnership with the Sealy Center for Vaccine Development at the University of Texas Medical Branch at Galveston. Publishing with the journal offers authors a number of benefits, including: Assurance of the highest possible publishing, editorial and production values, guided by Nature-codified standards. Open access: a recent study* indicates that open access articles may result in increased visibility and citation of your research. Professionally written Editorial Summaries to accompany each article summarizing the key issues addressed, with the goal of keeping the readership informed of advances in the field of vaccinology. Comprehensive and rigorous peer review: manuscripts are evaluated by experienced editors and reviewers who are authorities in the field. Wide dissemination and global reach: articles published under a Creative Commons license are permanently and freely available for all to read, use and cite without restriction, whilst authors retain the copyright to their article. Compliance with international open access funding mandates. Visit the journal website to learn more about npj Vaccines, including the full aims & scope. For guidance on the open access funding available to you, email openaccess@nature.com. npj Vaccines will publish research in the following areas: Discovery and basic science • Nonclinical development of vaccines • Biodefense vaccine AIDS vaccine • Vaccine formulation • Vaccine adjuvants and conjugate vaccines Cancer/oncology vaccines • Clinical evaluation of vaccines • Vaccine safety • DNA vaccines Regulatory science • Conventional and non-conventional vaccines • Live, attenuated vaccines Inactivated vaccines • Subunit vaccines • Toxoid vaccines • Recombinant vector vaccines Editor   Submit a Manuscript   Free article e-alerts Published in partnership with: Part of the Nature Partner Journals series *An independent study carried out by the Research Information Network of articles published in Nature Communications found that open access articles are viewed three times more often than articles that are only available to subscribers www.nature.com/npjvaccines As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive product information and special offers. If you no longer wish to receive these e-mails please unsubscribe here or to edit your Nature Publishing Group email services please click here to modify your account (Log in to be recognised as a Nature.com registrant). For further information on technical assistance | print subscriptions | other enquiries. Nature Publishing Group | Principal offices: London | New York and Tokyo and offices in cities worldwide including Basingstoke | Boston | Buenos Aires | Delhi | Madrid | Melbourne | Mexico City | Munich | Paris | San Francisco | Sao Paulo | Seoul | Shanghai and Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | US © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All rights reserved.